Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2022
Source ID
10.1016/j.msard.2022.104025

Entities

People

  • Benjamin L Greenberg
  • Brian Weinshenker
  • Francesco Patti
  • H.-christian Von Büdingen
  • Jerome De Seze
  • Kristina Weber
  • Michael R. Yeaman
  • Patricia Lobo
  • Takashi Yamamura
  • Xiujing Kou

Organizations

  • Chugai Pharmaceutical Co.
  • Hoffmann-La Roche
  • National Institutes of Health
  • United States Department of Defense